Jay Rughani

5 leading digital health founders - from GoodRx, Headway, Incredible Health, Komodo, and Owkin - on how to build multi-sided networks in healthcare

Annie Collins is an investing partner on the Bio + Health team, focusing on healthcare technology companies broadly, but is especially interested in

Building specialist AIs to perform healthcare tasks offers the most challenging technical problems in the field today, as well as the greatest opportunity for impact.

All this to say—it’s time to figure out how to access, pay for, and deliver curative therapies (amongst other high-cost, complex, specialty drugs), at scale. Let’s dive into the specific challenges that need to be surmounted to get this right.

Today, we are thrilled to announce our investment in Alchemy as they work to better connect our life sciences and healthcare delivery systems and solve these supply-demand mismatches in the pharmaceutical value chain. Alchemy has emerged to empower the long tail of independent providers with the physical, clinical, and digital infrastructure they need to fully serve their patient communities effectively, and profitably.